Stockreport

Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025

Travere Therapeutics, Inc.  (TVTX) 
PDF Late-breaking oral presentation details partial and complete proteinuria remission data from the DUPLEX Study of FILSPARI in FSGSData presentations highlight SPARTAN Stu [Read more]